Skilled panel says new $56Okay Alzheimer’s drug is unproven—and price $8,400 max

Enlarge / The outside of the headquarters of biotechnology firm Biogen in Cambridge, Massachusetts. (credit score: Getty | Boston Globe) Biogen’s new Alzheimer’s drug Aduhelm continues to face opposition after… Read more